businesspress24.com - REMINDER: Repros to Hold Analyst & Investor Day in New York on January 25th, 2012
 

REMINDER: Repros to Hold Analyst & Investor Day in New York on January 25th, 2012

ID: 1075781

(firmenpresse) - THE WOODLANDS, TX -- (Marketwire) -- 01/24/12 -- Repros Therapeutics Inc.® (NASDAQ: RPRX)
today reminds investors that it will hold an Analyst and Investor Day on
Wednesday, January 25, 2012. Presentations will be from 9:00am to 12:00pm
(EST) at the Millennium Broadway Hotel located at 145 West 44th Street,
NYC. The Company has arranged for outside Key Opinion Leaders (KOLs) to be
present to discuss the Company's clinical programs for both Androxal® and
Proellex®. Space at the event is limited and requests to attend from
institutional investors and sell side analysts should be sent to
. This event will also be broadcast live on the
company's web site at beginning at 9:00am the day of the
event.

About Repros Therapeutics Inc.

Repros Therapeutics focuses on the development of small molecule drugs for
major unmet medical needs that treat male and female reproductive
disorders.

Any statements made by the Company that are not historical facts contained
in thisrelease are forward-looking statements that involve risks and
uncertainties, including the ability to raise additional needed capital on
a timely basis in order for it to continue to fund development of its
Androxal® and Proellex® programs, have success in the clinical
development of its technologies, the reliability of interim results to
predict final study outcomes, and such other risks which are identified in
the Company's most recent Annual Report on Form 10-K and in any subsequent
quarterly reports on Form 10-Q. These documents are available on request
from Repros Therapeutics or at . Repros disclaims any intention
or obligation to update or revise any forward-looking statements, whether
as a result of new information, future events or otherwise.

For more information, please visit the Company's website at
.






Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:



Leseranfragen:



PresseKontakt / Agentur:



drucken  als PDF  an Freund senden  Coldstream Laboratories Announces Manager of Technology Transfer
Marina Biotech Starts Cohort 2 of Its Phase 1b START-FAP Clinical Trial of CEQ508
Bereitgestellt von Benutzer: MARKETWIRE
Datum: 24.01.2012 - 07:30 Uhr
Sprache: Deutsch
News-ID 1075781
Anzahl Zeichen: 0

contact information:
Contact person:
Town:

THE WOODLANDS, TX


Phone:

Kategorie:

Drugs


Anmerkungen:


Diese Pressemitteilung wurde bisher 96 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"REMINDER: Repros to Hold Analyst & Investor Day in New York on January 25th, 2012
"
steht unter der journalistisch-redaktionellen Verantwortung von

Repros Therapeutics (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Repros Therapeutics



 

Who is online

All members: 10 565
Register today: 0
Register yesterday: 2
Members online: 0
Guests online: 69


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.